www.neomatrix.com - HALO is FDA-cleared for the collection of nipple aspirate fluid for cytological evaluation. Like the Pap test for cervical cancer, HALO looks for cellular changes years before breast cancer might develop. Multiple studies have shown that if a woman has abnormal cells in the breast ducts, she has a 4-5 times greater risk of developing breast cancer. More at www.neomatrix.com